Literature DB >> 210837

Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins.

G Scherphof, F Roerdink, M Waite, J Parks.   

Abstract

1. During in vitro incubation of liposomes or unilamellar vesicles prepared from egg-yolk or rat-liver phosphatidylcholine with human, monkey or rat plasma the phospholipid becomes associated with a high molecular weight protein-containing component. 2. The phosphatidylcholine . protein complex thus formed co-chromatographs with high-density lipoprotein on Ultrogel AcA34 and has the same immunoelectrophoretic properties as this lipoprotein. 3. Release of the phosphatidylcholine from liposomes was also observed when liposomes were incubated with pure monkey high-density lipoproteins. Under those conditions some transfer of protein from the lipoprotein to the liposomes was observed as well. 4. The observed release of phospholipid from the liposomes is a one-way process, as the specific radioactivity of liposome-associated phosphatidylcholine remained constant during incubation with plasma. 5. It is concluded that either the lipoprotein particle takes up additional phospholipid or that a new complex is formed from protein constituents of the lipoprotein and the liposomal phosphatidylcholine. 6. Massive release of entrapped 125I-labeled albumin from the liposome during incubation with plasma suggests that the observed release of phosphatidylcholine from the liposomes has a highly destructive influence on the liposomal structure. 7. Our results are discussed with special reference to the use of liposomes as intravenous carriers of drugs and enzymes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210837     DOI: 10.1016/0304-4165(78)90025-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.

Authors:  Christopher G England; M Clarke Miller; Ashani Kuttan; John O Trent; Hermann B Frieboes
Journal:  Eur J Pharm Biopharm       Date:  2015-03-07       Impact factor: 5.571

2.  In vitro and in vivo studies evaluating a liposome system for drug solubilization.

Authors:  D M Lidgate; P L Felgner; J S Fleitman; J Whatley; R C Fu
Journal:  Pharm Res       Date:  1988-12       Impact factor: 4.200

Review 3.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

4.  Temperature-sensitive liposome-mediated delivery of thrombolytic agents.

Authors:  Vishal Saxena; Carmen Gacchina Johnson; Ayele H Negussie; Karun V Sharma; Matthew R Dreher; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2015-03-13       Impact factor: 3.914

5.  Influence of liposome charge and composition on their interaction with human blood serum proteins.

Authors:  T Hernández-Caselles; J Villalaín; J C Gómez-Fernández
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

6.  Porphyrin-phospholipid liposomes with tunable leakiness.

Authors:  Dandan Luo; Kevin A Carter; Aida Razi; Jumin Geng; Shuai Shao; Cuiyan Lin; Joaquin Ortega; Jonathan F Lovell
Journal:  J Control Release       Date:  2015-11-11       Impact factor: 9.776

7.  Entrapment of human leukocyte interferon in the aqueous interstices of liposomes.

Authors:  P Anderson; J Vilcek; G Weissmann
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

8.  Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).

Authors:  Stephan Holzschuh; Kathrin Kaeß; Alfred Fahr; Christiane Decker
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

9.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

Authors:  C Kirby; J Clarke; G Gregoriadis
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

10.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

Authors:  R Gref; A Domb; P Quellec; T Blunk; R H Müller; J M Verbavatz; R Langer
Journal:  Adv Drug Deliv Rev       Date:  1995-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.